HSPA5 and acute myeloid leukemia: We also tested the therapeutic efficacy of GRP78-CAR T cells by intravenous injection of AML KG1a-Luci cells into NSG mice, and the groups of mice treated with Non-CAR T cells, MOCK-CAR T cells, or GRP78-CAR T cells were monitored by bioluminescence at indicated days post injection (Supplementary Figure S3A).